EUVIMEDEUVIMED entdecken
Crossref

Screening for potentially teratogenic medications in the hospital setting: a necessity or a luxury?

Michael Ceulemans iD, Lynn Bruyninckx, Evelyne Van den Broucke, Karel Allegaert, Kristel Van Calsteren, Isabel Spriet, Charlotte Quintens

International Journal of Pharmacy Practice · 21.08.2026

DOI: 10.1093/ijpp/riag101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmacy Practice, online erschienen am 21.08.2026. Verfasst von Michael Ceulemans und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium. Die Arbeit nennt 10 Literaturangaben. Gefördert von: Senior Postdoctoral Fellowship fundamental research of the Research Foundation Flanders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study assessed the frequency and type of potentially teratogenic medications administered to hospitalized pregnant women.

Methods

A retrospective study was conducted among pregnant women hospitalized between 2021 and 2023. Key findings Among 155 individuals, 1058 medications were administered (mean: 6.8 per patient), including 77 potentially teratogenic medications (7.3%), corresponding to 27.1% of the cohort. Indomethacin (18.7%), tramadol (18.1%), and sufentanil (7.7%) were most common. Such medications were used nearly twice as often during non-pregnancy versus pregnancy-related admissions (12.7% vs. 6.8%).

Conclusions

The findings support the potential value of pregnancy-related monitoring, however, improving pregnancy documentation, especially in non-obstetric wards, remains essential.

Schlagwörter

Stichwörter der Autor:innen

check of medication appropriatenessclinical pharmacydrug safetypharmacovigilancepregnancyteratology

Autor:innen und Institutionen

  • Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium.
  • L-C&Y, KU Leuven Child & Youth Institute, 3000 Leuven, Belgium.
  • Research Foundation Flanders (FWO), 1000 Brussels, Belgium.
  • Faculty of Pharmaceutical Sciences, KU Leuven, 3000 Leuven, Belgium.
  • Pharmacy Department, University Hospitals Leuven, 3000 Leuven, Belgium.
  • Department of Development and Regeneration, KU Leuven, 3000 Leuven, Belgium.

ORCID-Profile: Michael Ceulemans

Förderung

  • Senior Postdoctoral Fellowship fundamental research of the Research Foundation Flanders

Zitieren

APA

Ceulemans, M., Bruyninckx, L., Van den Broucke, E., Allegaert, K., Van Calsteren, K., Spriet, I., & Quintens, C. (2026). Screening for potentially teratogenic medications in the hospital setting: a necessity or a luxury?. International Journal of Pharmacy Practice. https://doi.org/10.1093/ijpp/riag101

Vancouver

Ceulemans M, Bruyninckx L, Van den Broucke E, Allegaert K, Van Calsteren K, Spriet I, et al. Screening for potentially teratogenic medications in the hospital setting: a necessity or a luxury?. International Journal of Pharmacy Practice. 2026. doi:10.1093/ijpp/riag101

BibTeX
@article{Ceulemans2026,
  author = {Ceulemans, Michael and Bruyninckx, Lynn and Van den Broucke, Evelyne and Allegaert, Karel and Van Calsteren, Kristel and Spriet, Isabel and Quintens, Charlotte},
  title = {Screening for potentially teratogenic medications in the hospital setting: a necessity or a luxury?},
  journal = {International Journal of Pharmacy Practice},
  year = {2026},
  doi = {10.1093/ijpp/riag101}
}
Kostenlos starten →